Irreversible Covalent Modification Of Type I Dehydroquinase: Structure-based Design And Simulation Studies | 24108
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A promising approach in the search of new antimicrobial or antivirulence agentsto combat resistant bacteria is a detailed
knowledge of the catalytic mechanism and the binding determinants of enzymes involved in biosynthetic pathways or
processes that no have mammalian homologues but they are essential for bacterial survival or relevant for virulence. That is the
case of the shikimic acid pathway enzymes, through which chorismic acid is biosynthesized. This compound is the precursor in
the synthesis of aromatic compounds, including the aromatic amino acids L-Phe, L-Tyr and L-Phe, folate cofactors, ubiquinone
and vitamins E and K. Here we report results from structural, biochemical and computational studies conducted to improve
our understanding of the third enzyme of the shikimic acid pathway, the type I dehydroquinase (DHQ1). This enzyme is a
class I aldolase that catalyzes the syn elimination of water in 3-dehydroquinic acid by multi-step mechanism that involves the
formation of a Schiff base. Several mimetics of the natural substrate were designed to study the substrate binding, the role of
the conserved residues and the substrate-covering loop, as well as the irreversible inhibition of the enzyme.The first crystal
structure of DHQ1 from Salmonella typhicovalently modified by a new irreversible inhibitor at 1.4 ? will be presented. This
structure revealed that the modified ligand is surprisingly covalently attached to the essential Lys170 by the formation of a
stable Schiff base and after several chemical modifications of the inhibitor.
Concepci?n Gonz?lez-Bello has obtained her PhD at the University of Santiago de Compostela (USC, Spain) in 1994. She did two predoctoral stays in the
University of Gent (Belgium) with Prof. Vandewalle and in the Scripps Research Institute (USA) with Prof. Nicolaou. After a postdoctoral stay in the University of
Cambridge (UK) with Prof. Abell, she joined USC as an Assistant Professor, was promoted to Associate Professor in 2003 and obtained the Spanish habilitation
to full Professor in 2011. She is author of more than 50 papers and several book chapters. She is a member of the ChemMedChem International Advisory Board.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals